AR067830A1 - Proteinas streptococcus inmunogenicas - Google Patents

Proteinas streptococcus inmunogenicas

Info

Publication number
AR067830A1
AR067830A1 ARP080103446A ARP080103446A AR067830A1 AR 067830 A1 AR067830 A1 AR 067830A1 AR P080103446 A ARP080103446 A AR P080103446A AR P080103446 A ARP080103446 A AR P080103446A AR 067830 A1 AR067830 A1 AR 067830A1
Authority
AR
Argentina
Prior art keywords
proteins
immunogenic
streptococcus
producing
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ARP080103446A
Other languages
English (en)
Inventor
Hilda Elizabeth Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AR067830A1 publication Critical patent/AR067830A1/es
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)

Abstract

La solicitud proporciona medios y métodos para identificar una proteína de streptococcus que sea capaz de producir una respuesta inmune en contra de a lo menos dos cepas y/lo serotipos de Streptococcus. La presente describe adicionalmente composiciones inmunogénicas capaces de producir una respuesta inmune en contra del Streptococcus uberis que comprenden a lo menos dos proteínas recombinantes y/o aisladas derivadas del Streptococcus uberis y/o parte inmunogénica o análogo o derivado de cualquiera o ambas dicha proteínas. La solicitud describe adicionalmente las moléculas del ácido nucleico que codifican dichas proteínas o partes inmunogénicas de esta, células huésped y portadores recombinantes que comprenden tal molécula de ácido nucleico y las vacunas y de pruebas de diagnostico basadas en dichas proteínas y ácidos nucleicos.
ARP080103446A 2007-08-06 2008-08-07 Proteinas streptococcus inmunogenicas Pending AR067830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
AR067830A1 true AR067830A1 (es) 2009-10-21

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103446A Pending AR067830A1 (es) 2007-08-06 2008-08-07 Proteinas streptococcus inmunogenicas

Country Status (19)

Country Link
US (1) US20100297183A1 (es)
EP (3) EP2023143A1 (es)
JP (2) JP5462164B2 (es)
KR (1) KR20100063706A (es)
CN (1) CN101821627A (es)
AR (1) AR067830A1 (es)
AU (1) AU2008284491A1 (es)
BR (1) BRPI0815604A2 (es)
CA (1) CA2695721A1 (es)
CL (1) CL2008002320A1 (es)
CO (1) CO6270172A2 (es)
DK (1) DK2183597T3 (es)
ES (1) ES2432407T3 (es)
MX (1) MX2010001482A (es)
RU (1) RU2518315C2 (es)
TW (1) TW200911999A (es)
UA (1) UA103885C2 (es)
WO (1) WO2009020391A1 (es)
ZA (1) ZA201000806B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1098980T3 (da) * 1998-07-22 2014-09-29 Stichting Dienst Landbouwkundi Streptococcus suis-vacciner og diagnostiske tests
JP4275413B2 (ja) * 2001-02-02 2009-06-10 イーデー−レーリスタット，インスティチュート フォール ディールハウデレイ エン ディールゲゾントヘイト ベー．フェー． ストレプトコッカス・スイスの環境的に調節された遺伝子
GB0818231D0 (en) * 2008-10-06 2008-11-12 Univ Nottingham Composition
CN109675026A (zh) * 2013-09-19 2019-04-26 硕腾服务有限责任公司 油基佐剂
WO2016102339A1 (en) * 2014-12-22 2016-06-30 F. Hoffmann-La Roche Ag Cell penetrating peptides
RU2757426C2 (ru) * 2015-10-21 2021-10-15 МинерваКС Апс Иммунногенный слитый белок
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
US20240024380A1 (en) * 2020-12-23 2024-01-25 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
WO1995031548A1 (en) * 1994-05-16 1995-11-23 The Uab Research Foundation Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
DK0900380T3 (da) 1996-04-26 2003-11-03 Seed Capital Investments Fremgangsmåde til udvælgelse og fremstilling af T-celle-peptid-epitoper og vacciner indeholdende disse udvalgte epitoper
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
DK1098980T3 (da) * 1998-07-22 2014-09-29 Stichting Dienst Landbouwkundi Streptococcus suis-vacciner og diagnostiske tests
JP4689044B2 (ja) * 1998-12-21 2011-05-25 メディミューン，インコーポレーテッド ワクチン用の肺炎連鎖球菌タンパク質と免疫原断片
AU780474B2 (en) * 1999-06-16 2005-03-24 Boston Biomedical Research Institute Incorporated Immunological control of beta-amyloid levels in vivo
EP1294771B1 (en) * 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
JP4275413B2 (ja) * 2001-02-02 2009-06-10 イーデー−レーリスタット，インスティチュート フォール ディールハウデレイ エン ディールゲゾントヘイト ベー．フェー． ストレプトコッカス・スイスの環境的に調節された遺伝子
EP1572975B1 (en) * 2002-11-26 2014-07-16 University Of Tennessee Research Foundation Streptococcus uberis adhesion molecule
US7745580B2 (en) * 2003-01-27 2010-06-29 Kobenhavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
EP2267006A1 (en) * 2003-05-30 2010-12-29 Intercell AG Enterococcus antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
HUE030269T2 (en) * 2006-06-26 2017-04-28 Macrogenics Inc FC RIIB-specific antibodies and methods for their use

Also Published As

Publication number Publication date
AU2008284491A1 (en) 2009-02-12
JP5462164B2 (ja) 2014-04-02
UA103885C2 (en) 2013-12-10
CA2695721A1 (en) 2009-02-12
KR20100063706A (ko) 2010-06-11
ES2432407T3 (es) 2013-12-03
BRPI0815604A2 (pt) 2015-03-03
EP2183597B1 (en) 2013-07-24
US20100297183A1 (en) 2010-11-25
WO2009020391A1 (en) 2009-02-12
EP2183597A1 (en) 2010-05-12
CO6270172A2 (es) 2011-04-20
JP2010535500A (ja) 2010-11-25
JP2014095721A (ja) 2014-05-22
EP2023143A1 (en) 2009-02-11
RU2518315C2 (ru) 2014-06-10
EP2660604A2 (en) 2013-11-06
TW200911999A (en) 2009-03-16
CN101821627A (zh) 2010-09-01
RU2010107878A (ru) 2011-09-20
CL2008002320A1 (es) 2009-09-25
EP2660604A3 (en) 2014-02-12
ZA201000806B (en) 2010-10-27
MX2010001482A (es) 2010-03-01
DK2183597T3 (da) 2013-10-14

Similar Documents

Publication Publication Date Title
AR067830A1 (es) Proteinas streptococcus inmunogenicas
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
BR112019006388A2 (pt) enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas
BR112016002614B8 (pt) Imunocitoquina e composição farmacêutica
BR112018070323A2 (pt) vacina contra rsv
BRPI1010830A2 (pt) Sequências de aminoácidos melhoradas direcionadas contra o vírus respiratório sencicial humano (hrsv) e polipetídeos que compreende os mesmos para prevenção e/ou tratamento de infecções do trato respiratório.
BRPI0806578A8 (pt) Promotores de lactococcus e usos dos mesmos
BRPI0707154B8 (pt) composição de vacina
BR112014018432A8 (pt) Proteína, composição imunogênica, método para produzir proteína e para tratar ou prevenir doença, molécula de ácido nucleico, vetor, célula hospedeira, uso de uma proteína, e, uso de uma composição imunogênica
BR112012009289A2 (pt) isolamento e purificação de anticorpos anti-il-13 com uso de cromatografia de afinidade com proteína a.
DK1709067T3 (da) Vacciner med underenhed af Lawsonia intracellularis
BR112015000585A8 (pt) método para preparar uma cepa mutante de mycoplasma hyopneumoniae, vetores, cepa mutante, vacina, kit de vacinação e usos do vetor e da cepa mutante
BR112012028893A2 (pt) composições imunoestimuladoras e de vacina
BR112015013387A2 (pt) proteínas tipo espiral enrolada modificadas possuindo propriedades melhoradas
BR112018075513A2 (pt) ácidos nucleicos que codificam as partículas seme-lhantes ao vírus da zika e seu uso nas vacinas e no ensaio de diagnóstico do vírus da zika
WO2017083729A3 (en) Fixatives and methods of use
WO2012149160A3 (en) Viruses modified with unnatural moieties and methods of use thereof
AU2014232363A8 (en) Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
PE20081687A1 (es) Proteina de fusion
BR112012024224A2 (pt) mutações da faixa de hospedeiro de flavivírus e seu uso.
BR112015032556A2 (pt) Proteína matriz (m) modificada de um vírus da estomatite vesicular (vsv); sequência de nucleotídeos que codifica uma proteína matriz modificada de um vírus da estomatite vesicular; vírus da estomatite vesicular recombinante (rvsv); vacina; vacina de combinação de preparação e reforço; kit; peptídeo isolado; sequências de nucleotídeos isoladas; uso da vacina; uso da vacina de combinação de preparação e reforço; método para induzir uma resposta imunológica em um indivíduo
DK1664100T3 (da) Vaccine med underenhed af Lawsonia intracellularis
WO2010058100A8 (fr) Protéines mutantes de la protéine f de piv-5 et de piv-2
BR112017024283A2 (pt) vacinas contra a dengue
BR112014007491A2 (pt) sequências de aminoácidos para o controle de patógenos

Legal Events

Date Code Title Description
FB Suspension of granting procedure